• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA22-80/I20-40
Medical Device Problem Codes Improper or Incorrect Procedure or Method (2017); Device-Device Incompatibility (2919)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 11/07/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.
 
Event or Problem Description
The patient was initially implanted with an afx2 bifurcated stent graft and a non - endologix stent (gore excluder leg)to treat an iliac artery aneurysm.This case is outside the indications of use (off -label).A possible intraoperative type 3b was reported at the end of the procedure.Approximately four days later, it was reported that the endoleak had resolved itself as there is no endoleak present.The patient will be monitored.
 
Additional Manufacturer Narrative
Clinical assessment of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Several requests were made for both; however, no response was received.As such, event determination, off label conditions, related patient harms and patient disposition could not be assessed.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Device iteration is afx2.Corrections: d4: expiration date/udi - updated.G1,2: contact office- name has been updated.H6: result code ¿ remove 3233.H6: conclusion code ¿ remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key9453386
Report Number2031527-2019-00600
Device Sequence Number3066735
Product Code MIH
UDI-Device Identifier00818009014955
UDI-Public(01)00818009014955(17)191129
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source distributor,foreign,health pr
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 11/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/29/2020
Device Model NumberBEA22-80/I20-40
Device Lot NumberBEA22-80/I20-40
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 11/11/2019
Supplement Date Received by Manufacturer11/11/2019
Initial Report FDA Received Date12/11/2019
Supplement Report FDA Received Date06/24/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0007-2019
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ENDOLOGIX STENT (GORE EXCLUDER LEG).
Outcome Attributed to Adverse Event Other;
Patient Age85 YR
-
-